WHO Halts Use of Euvax B Vaccine for Hepatitis B (Vietnam)
This article was originally published in PharmAsia News
The World Health Organization (WHO) has suspended the use of the Euvax B vaccine for hepatitis B worldwide following the deaths of three infants in Vietnam. The vaccine was made by LG company in Korea but reportedly was imported without verification into Vietnam. A government group is investigating the cases and includes representatives of the National Institute of Hygiene and Epidemiology, the Expanded Programme for Immunization, the National Hospital of Pediatrics, the WHO, and UNICEF. (Click here for more
You may also be interested in...
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.
Poseida, Nkarta and Inventiva raised $224m, $252m and $107.7m, respectively. Also, Forbion raised €185m ($208m) of a new €250m fund and Blackstone closed the last $1.2bn of its $4.6bn fund for public and private company deals, and Ascendis led recent follow-ons with a $569.2m offering.